Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancers|January 10, 2026
Outcomes of pPCL Diagnosed Using the IMWG 2021 Consensus Definition: A Retrospective Multicenter AnalysisPriyanka Venkatesh, Razan Mansour, Yara Shatnawi, et al.
Cancers|December 11, 2025
Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled TrialsZain Alsaddi, Osama Younis, Ghena Khasawneh, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2025
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM)Cindy Varga, Kip D Zimmerman, David M Foureau, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 11, 2020
PINK1-Dependent Mitophagy Regulates the Migration and Homing of Multiple Myeloma Cells via the MOB1B-Mediated Hippo-YAP/TAZ PathwayShengjun Fan, Trevor Price, Wei Huang, et al.
Cancers|September 14, 2024
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple MyelomaBarry Paul, Faiz Anwer, Shahzad Raza, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2023
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)Hamid Ehsan, Alec Britt, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based RegimensJai N Patel, Myra Robinson, Megan Jagosky, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With DaratumumabDonald C Moore, Justin R Arnall, Daniel L Thompson, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 14, 2020
Safety and Cost Benefits of the Rapid Daratumumab Infusion ProtocolIssam S Hamadeh, Emily S Reese, Justin R Arnall, et al.
Blood Cancer Journal|August 1, 2025
Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myelomaMobina Golmohammadi, Shahzad Raza, Maram Albayyadhi, et al.
Pageof 5